Humedix Co., Ltd. (KOSDAQ:200670)

South Korea flag South Korea · Delayed Price · Currency is KRW
38,900
-700 (-1.77%)
Mar 28, 2025, 3:30 PM KST
31.86%
Market Cap 401.01B
Revenue (ttm) 110.99B
Net Income (ttm) 9.06B
Shares Out 10.31M
EPS (ttm) 963.99
PE Ratio 40.35
Forward PE 9.13
Dividend 550.00 (1.39%)
Ex-Dividend Date Mar 28, 2025
Volume 145,342
Average Volume 128,546
Open 39,600
Previous Close 39,600
Day's Range 38,050 - 39,750
52-Week Range 25,400 - 46,450
Beta 0.55
RSI 47.27
Earnings Date May 9, 2025

About Humedix

Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea. [Read more]

Sector Healthcare
Founded 2002
Employees 248
Stock Exchange KOSDAQ
Ticker Symbol 200670
Full Company Profile

Financial Performance

In 2021, Humedix's revenue was 110.99 billion, an increase of 12.70% compared to the previous year's 98.48 billion. Earnings were 9.06 billion, a decrease of -39.91%.

Financial Statements

News

There is no news available yet.